308 related articles for article (PubMed ID: 21683401)
1. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice.
Choi DE; Jeong JY; Lim BJ; Chang YK; Na KR; Shin YT; Lee KW
J Urol; 2011 Aug; 186(2):694-701. PubMed ID: 21683401
[TBL] [Abstract][Full Text] [Related]
2. The synergistic effect of mizoribine and a direct renin inhibitor, aliskiren, on unilateral ureteral obstruction induced renal fibrosis in rats.
Sakuraya K; Endo A; Someya T; Hirano D; Murano Y; Fujinaga S; Ohtomo Y; Shimizu T
J Urol; 2014 Apr; 191(4):1139-46. PubMed ID: 24140549
[TBL] [Abstract][Full Text] [Related]
3. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
Chung S; Jeong JY; Chang YK; Choi DE; Na KR; Lim BJ; Lee KW
Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin attenuates renal injury in an experimental model of rat unilateral ureteral obstruction via anti-inflammatory and anti-apoptotic effects.
Chang YK; Choi DE; Na KR; Lee SJ; Suh KS; Kim SY; Shin YT; Lee KW
J Urol; 2009 Mar; 181(3):1434-43. PubMed ID: 19157461
[TBL] [Abstract][Full Text] [Related]
5. Aliskiren restores renal AQP2 expression during unilateral ureteral obstruction by inhibiting the inflammasome.
Wang W; Luo R; Lin Y; Wang F; Zheng P; Levi M; Yang T; Li C
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F910-22. PubMed ID: 25694485
[TBL] [Abstract][Full Text] [Related]
6. A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren.
Wu WP; Chang CH; Chiu YT; Ku CL; Wen MC; Shu KH; Wu MJ
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F929-41. PubMed ID: 20685818
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury--beyond the direct renin inhibition.
Sun CY; Cherng WJ; Jian HZ; Hsu HH; Wu IW; Hsu HJ; Wu MS
Hypertens Res; 2012 Mar; 35(3):304-11. PubMed ID: 22089535
[TBL] [Abstract][Full Text] [Related]
8. Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.
Chung S; Kim S; Kim M; Koh ES; Shin SJ; Park CW; Chang YS; Kim HS
PLoS One; 2017; 12(7):e0181757. PubMed ID: 28753620
[TBL] [Abstract][Full Text] [Related]
9. Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease.
Lizakowski S; Tylicki L; Renke M; Rutkowski P; Heleniak Z; Sławińska-Morawska M; Aleksandrowicz-Wrona E; Małgorzewicz S; Rutkowski B
Am J Hypertens; 2012 Jun; 25(6):636-9. PubMed ID: 22357413
[TBL] [Abstract][Full Text] [Related]
10. Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction?
Miyajima A; Ito K; Asano T; Seta K; Ueda A; Hayakawa M
J Urol; 2001 Sep; 166(3):1124-9. PubMed ID: 11490310
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
[TBL] [Abstract][Full Text] [Related]
12. Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction.
Uchida Y; Miyajima A; Kikuchi E; Kozakai N; Kosaka T; Ieda M; Fukuda K; Ohigashi T; Oya M
Urology; 2009 Oct; 74(4):938-43. PubMed ID: 19428059
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin increases renal nitric oxide production and ameliorates renal injury in mice with unilateral ureteral obstruction.
Ito K; Yoshii H; Asano T; Seta K; Mizuguchi Y; Yamanaka M; Tokonabe S; Hayakawa M; Asano T
J Urol; 2010 Apr; 183(4):1630-5. PubMed ID: 20172553
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanism.
Yen TH; Yang HY; Yeh YH; Chu PH; Wen CJ; Fu JF; Wang IK; Liang CC; Chang CT; Chen KH; Tian YC; Hung CC; Lin JL; Yang CW
Lupus; 2013 Feb; 22(2):180-9. PubMed ID: 23257405
[TBL] [Abstract][Full Text] [Related]
15. The role of nitric oxide in obstructive nephropathy.
Huang A; Palmer LS; Hom D; Valderrama E; Trachtman H
J Urol; 2000 Apr; 163(4):1276-81. PubMed ID: 10737528
[TBL] [Abstract][Full Text] [Related]
16. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
Horký K
Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction.
Kellner D; Chen J; Richardson I; Seshan SV; El Chaar M; Vaughan ED; Poppas D; Felsen D
J Urol; 2006 Aug; 176(2):806-12. PubMed ID: 16813952
[TBL] [Abstract][Full Text] [Related]
18. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction.
Liang J; Tian S; Han J; Xiong P
Ren Fail; 2014 Mar; 36(2):285-91. PubMed ID: 24152192
[TBL] [Abstract][Full Text] [Related]
20. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
